Implantable venous port-related infections in cancer patients
- PMID: 14727170
- DOI: 10.1007/s00520-003-0576-z
Implantable venous port-related infections in cancer patients
Abstract
Objectives: To evaluate the characteristics of implantable venous port-related infections in patients with malignancies.
Patients and methods: This was a 6-year study in which all the records of cancer patients who were diagnosed with port-related infections were retrospectively analyzed.
Results: The analysis included 36 episodes of port-related infections. The median period from port implantation to the episode of port-related infection was 164 days (21 to 1650 days). Of the 36 episodes, 15 (42%) were polymicrobial infections, and 21 (58%) were gram-negative pathogens. If only the port-related bacteremia was taken into consideration, gram-negative bacilli and gram-positive cocci accounted for 39 and 7 pathogens of the total 53 isolated microorganisms (74% and 13%, respectively). Stenotrophomonas maltophilia and Acinetobacter baumanii were the predominant causal microorganisms. All except two infectious catheters were removed. No infection-related mortality developed.
Conclusions: Gram-negative bacilli, especially the glucose-non-fermenting pathogens, tend to be the major microorganisms that account for port-related infections, and the infections run a benign course, even those developed in septicemia.
Similar articles
-
Symptoms and signs of port-related infections in oncology patients related to the offending pathogens.Int J Clin Pract. 2008 Aug;62(8):1193-8. doi: 10.1111/j.1742-1241.2008.01746.x. Epub 2008 Apr 14. Int J Clin Pract. 2008. PMID: 18422589
-
Epidemiology of device-associated infections related to a long-term implantable vascular access device.Infect Control Hosp Epidemiol. 1999 Mar;20(3):187-91. doi: 10.1086/501609. Infect Control Hosp Epidemiol. 1999. PMID: 10100545
-
Infectious morbidity associated with long-term use of venous access devices in patients with cancer.Ann Intern Med. 1993 Dec 15;119(12):1168-74. doi: 10.7326/0003-4819-119-12-199312150-00003. Ann Intern Med. 1993. PMID: 8239247
-
Guidelines for the management of intravascular catheter-related infections.J Intraven Nurs. 2001 May-Jun;24(3):180-205. J Intraven Nurs. 2001. PMID: 11530364 Review.
-
Port-A-Cath infections in children with cancer.Eur J Cancer. 2004 Nov;40(16):2452-8. doi: 10.1016/j.ejca.2004.07.017. Eur J Cancer. 2004. PMID: 15519519 Review.
Cited by
-
Influence of Intratumor Microbiome on Clinical Outcome and Immune Processes in Prostate Cancer.Cancers (Basel). 2020 Sep 5;12(9):2524. doi: 10.3390/cancers12092524. Cancers (Basel). 2020. PMID: 32899474 Free PMC article.
-
Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli.World J Surg Oncol. 2015 Sep 30;13:288. doi: 10.1186/s12957-015-0707-2. World J Surg Oncol. 2015. PMID: 26420628 Free PMC article.
-
Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis.Support Care Cancer. 2009 Mar;17(3):285-93. doi: 10.1007/s00520-008-0481-6. Epub 2008 Jul 29. Support Care Cancer. 2009. PMID: 18663483
References
MeSH terms
LinkOut - more resources
Full Text Sources